Search Results - Wilson, Catheryn

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice

    Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male m... by Wilson, Catheryn D., Zheng, Fang, Fantegrossi, William E.

    Published in Psychopharmacology
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal

    Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawa... by Wilson, Catheryn D., Hiranita, Takato, Fantegrossi, William E.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems

    Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems by Fantegrossi, William E., Wilson, Catheryn D., Berquist, Michael D.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice

    Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice by Wilson, Catheryn D, Tai, Sherrica, Ewing, Laura, Crane, Jasmine, Lockhart, Taylor, Fujiwara, Ryochi, Radominska-Pandya, Anna, Fantegrossi, William E

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice

    The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice by Crowe, Molly S, Wilson, Catheryn D, Leishman, Emma, Prather, Paul L, Bradshaw, Heather B, Banks, Matthew L, Kinsey, Steven G

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development

    Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development by Ford, Benjamin M., Franks, Lirit N., Tai, Sherrica, Fantegrossi, William E., Stahl, Edward L., Berquist, Michael D., Cabanlong, Christian V., Wilson, Catheryn D., Penthala, Narsimha R., Crooks, Peter A., Prather, Paul L.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome

    In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome by Griffin, Bryce A., Caperton, Caitlin O., Russell, Lauren N., Cabanlong, Christian V., Wilson, Catheryn D., Urquhart, Kyle R., Martins, Bradford S., Zita, Marcelle Dina, Patton, Amy L., Alund, Alexander W., Owens, S. Michael, Fantegrossi, William E., Moran, Jeffery H., Brents, Lisa K.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC

    Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ9-THC by Hutchison, Rachel D., Ford, Benjamin M., Franks, Lirit N., Wilson, Catheryn D., Yarbrough, Azure L., Fujiwara, Ryoichi, Su, Mark K., Fernandez, Denise, James, Laura P., Moran, Jeffery H., Patton, Amy L., Fantegrossi, William E., Radominska-Pandya, Anna, Prather, Paul L.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice

    Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice by Tai, Sherrica, Vasiljevik, Tamara, Sherwood, Alexander M., Eddington, Sarah, Wilson, Catheryn D., Prisinzano, Thomas E., Fantegrossi, William E.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  10. 10
    Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development

    Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development by Ford, Benjamin M, Franks, Lirit N, Tai, Sherrica, Fantegrossi, William E, Stahl, Edward L, Berquist, Michael D, Cabanlong, Christian V, Wilson, Catheryn D, Penthala, Narsimha R, Crooks, Peter A, Prather, Paul L

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  11. 11
    2421 Development and validation of a translational rat model of neonatal abstinence syndrome

    2421 Development and validation of a translational rat model of neonatal abstinence syndrome by Brents, Lisa, Griffin, Bryce A., Caperton, Caitlin, Russell, Lauren, Cabanlong, Christian, Wilson, Catheryn, Urquhart, Kyle, Martins, Brad, Patton, Amy L., Alund, Alexander W., Owens, S. Michael, Fantegrossi, William E., Moran, Jeffery H.

    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    In vitro and In vivo Effects of Phase 1 Hydroxylated Metabolites of the Synthetic Cannabinoid AB‐PINACA [(S)‐N‐(1‐amino‐3‐methyl‐1‐oxobutan‐2‐yl)‐1‐pentyl‐1H‐indazole‐3‐carboxamide]

    In vitro and In vivo Effects of Phase 1 Hydroxylated Metabolites of the Synthetic Cannabinoid AB‐PINACA [(S)‐N‐(1‐amino‐3‐methyl‐1‐oxobutan‐2‐yl)‐1‐pentyl‐1H‐indazole‐3‐carboxamide... by Wilson, Catheryn D., Hutchison, Rachel D., Ford, Benjamin M., Prather, Paul L., Fantegrossi, William E.

    Published in The FASEB journal
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ 9 -THC

    Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ 9 -THC by Hutchison, Rachel D, Ford, Benjamin M, Franks, Lirit N, Wilson, Catheryn D, Yarbrough, Azure L, Fujiwara, Ryoichi, Su, Mark K, Fernandez, Denise, James, Laura P, Moran, Jeffery H, Patton, Amy L, Fantegrossi, William E, Radominska-Pandya, Anna, Prather, Paul L

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: